Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/KRYS

KRYS

Krystal Biotech, Inc.

Healthcare - US

Krystal Biotech, Inc. specializes in the development and commercialization of genetic medicines, focusing on redosable gene therapies for severe, life-threatening, or rare diseases, primarily in dermatology. Its core product is VYJUVEK (ber…

HQ: Pittsburgh, PA, United States of Americawww.krystalbio.com

USD347.00+0.42%vs prev. close

Market snapshot

Price

USD347.00

Daily move

+0.42%

P/E

43.3

EPS TTM

8.01

Dividend yield

—

Beta

0.54

Market cap

10.3B

Price history

KRYS price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Krystal Biotech	KRYS	Biotechnology	10.3	43.3	—	-3.1%	+4.3%	+9.1%	+40.3%	+140.4%	+40.8%

Subscribe to Equity Analytics to compare KRYS with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.